Displaying drugs 151 - 175 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Necitumumab | Not Available |  | A monoclonal antibody used to treat metastatic squamous non-small cell lung cancer. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Naxitamab | 144000.0 |  | A GD2-targeted IgG1 monoclonal antibody for the treatment of high-risk relapsed/refractory neuroblastoma of the bone or bone marrow. | Glycolipid Disialoganglioside-directed Antibody |
| Natalizumab | 149000.0 |  | A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. | Selective Immunosuppressants |
| Muromonab | 146189.7 C6460H9946N1720O2043S56 |  | A monoclonal anti-CD3 antibody used as immunosuppressive therapy in kidney, heart, and liver transplant patients. | Selective Immunosuppressants |
| Moxetumomab pasudotox | 63500.0 C2804H4339N783O870S14 |  | A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. | CD22 (Clusters of Differentiation 22) inhibitors |
| Motixafortide | 2159.6 C97H144FN33O19S2 | | A peptide inhibitor of CXCR4 used to mobilize hematopoietic stem cells prior to collection and autologous transplantation in multiple myeloma patients. | Amino Acids, Peptides, and Proteins / Hematopoietic Stem Cell Mobilizer / Peptides |
| Mosunetuzumab | 146300.0 C6515H10031N1725O2025S43 | | A humanized anti-CD20/CD3 bispecific antibody used to treat relapsed or refractory follicular lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antineoplastic Agents / Blood Proteins / Cancer immunotherapy / CD20-directed Antibody Interactions / CD3-directed Antibody Interactions / Immunoglobulins / Immunosuppressive Agents / Immunotherapy / Myelosuppressive Agents / Proteins / Serum Globulins |
| Moroctocog alfa | 173000.0 | | A recombinant Factor VIII used to treat hemophilia A to control bleeding. | Recombinant Proteins |
| Mogamulizumab | Not Available | | A monoclonal antibody used to treat relapsed or refractory mycosis fungoides or Sézary syndrome after attempting one other therapy. | Antibodies, Monoclonal / Chemokine Receptor Type 4 Interaction |
| Mirvetuximab soravtansine | 150000.0 | | A folate receptor alpha-directed antibody and microtubule inhibitor conjugate used to treat folate receptor alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibody-drug Conjugates / Antineoplastic Agents / Blood Proteins / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoconjugates / Immunoglobulins / Immunologic Factors / Immunoproteins / Lactams, Macrocyclic / Lactones / Microtubule Inhibition / P-glycoprotein substrates / Proteins / Serum Globulins |
| Mirikizumab | 147000.0 | | An anti-IL-23 monoclonal antibody used as a second-line therapy for moderate-to-severe active ulcerative colitis. | Anti-Ulcer Agents / Gastrointestinal Agents |
| Metreleptin | 16155.4429 C714H1167N191O221S6 |  | A leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy. | Amino Acids and Derivatives |
| Methoxy polyethylene glycol-epoetin beta | Not Available | | A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. | Erythropoiesis-Stimulating Agents |
| Mepolizumab | 149000.0 |  | A fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. | Interleukin-5 Antagonist |
| Menotropins | 23390.3 C1014H1609N287O294S27 |  | A purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility. | Biological Products / Fertility Agents, Female / Gonadotropins / Gonadotropins, Pituitary |
| Mecasermin rinfabate | Not Available | | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... | Somatropin and Somatropin Agonists |
| Mecasermin | 7649.0 C331H518N94O101S7 |  | A recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH. | Somatropin and Somatropin Agonists |
| Maftivimab | 143948.11 C6368H9886N1706O2008S46 | | Part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells. | Antiviral Agents |
| Lyme disease vaccine (recombinant OspA) | 27743.1 C1198H2012N322O422S2 |  | For prophylactic treatment of Lyme Disease | Not Available |
| Lutropin alfa | 30000.0 C1014H1609N287O294S27 |  | A form of recombinant human luteinizing hormone used to treat female infertility due to hypothalamic or pituitary insufficiency, or due to profound luteinizing hormone deficiency. | Gonadotropins |
| Luteinizing hormone | Not Annotated | | Not Annotated | Gonadotropins, Pituitary |
| Luspatercept | 76000.0 | | An erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. | Hematinics |
| Lucinactant | 2470.2 C 126 H 238 N 26 O 22 | | Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | Pulmonary Surfactants |
| Loncastuximab tesirine | 151000.0 | | An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas. | Antineoplastic Agents, Immunological |
| Lixisenatide | 4858.0 | | A GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
Displaying drugs 151 - 175 of 407 in total